Gilead Sciences
Price & Volume
Stats
See more52W Range | $106.44-$155.38 |
Market Cap | $183.6B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $30.4B |
Revenue Growth (YoY) | 10.2% |
Gross Profit (12 Mos) | $24.2B |
Diluted EPS | -$2.64 |
News
See moreYahoo Finance • 2 days ago
Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
Yahoo Finance • 5 days ago
Gilead’s HIV Business is Surging, but is the Company Too Dependent on One Franchise?
Yahoo Finance • 5 days ago
Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?
Yahoo Finance • 5 days ago
Pfizer vs. Gilead: Which Drugmaker Has the Stronger Growth Story?
About
CEO | Mr. Daniel Patrick O'Day |
CFO | Mr. Andrew D. Dickinson |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,000 |